Mar 11, 2016
Pharmaceutical Executive
Positioning for success in biopharma requires a self-critical analysis of the risk and rewards among four categories of value differentiation. The key question: How do you define yourself against the competition?
Mar 01, 2016
Bruno Villetelle discusses how Japanese companies like Takeda have begun to digitize in order to care for the country's aging population.
Feb 12, 2016
The recent formation of mega supply-chain purchasing groups such as CVS-Cardinal denotes a shift in the balance of power between wholesalers, chains, generics companies and branded pharma.
Feb 05, 2016
Pharm Exec talks to Jane Griffiths, Company Group Chairman, Janssen EMEA, about how the relationship between industry and patients is maturing.
Feb 05, 2016
Pharmaceutical Executive
An advocate of supply chain business system automation offers a six-pronged approach to adapting to a new age of mounting regulation and customer expectations.
Jan 28, 2016
Companies must design local commercial models that enable them to deliver value stories tailored to the specific needs of organized customers and the characteristics of local ecosystems, writes Paul Darling.
Jan 28, 2016
Julian Upton sits down with Subhanu Saxena for an update on Cipla's plans to leverage its historic visibility as an emerging market champion to the next level of global leadership in biopharma.
Dec 08, 2015
Pharmaceutical Executive
Four years after first meeting Steve Collis, Pharm Exec catches up with the AmerisourceBergen CEO to see how he’s faring on the central question of leadership—can one man change a company?
Nov 29, 2015
As vital contributors to hospital disaster preparedness, the pharma industry has a role to play in making sure medical networks have what they need to meet the unforeseen, including future disasters.
Nov 24, 2015
Hightlights of Peter Young and Brent Saunders's "fireside chat" about the Allergan CEO’s early entrepreneurial years, his career in the industry, and some of his business philosophies.
lorem ipsum